Harvest operations for recombinant proteins
Abstract
The present invention contemplates a method of producing a recombinant protein comprising (a) fermenting a prokaryotic host cell wherein said prokaryotic host cell has been transformed with a nucleic acid encoding said recombinant protein, and (b) harvesting said recombinant protein under conditions where dO2 levels are greater than 0%, and (c) purifying said recombinant protein to a filtered bulk, wherein said filtered bulk does not contain detectable DHNA-recombinant protein adduct, as measured by an IEC assay at 310 nm. The present invention also contemplates a method of producing a recombinant protein comprising (a) fermenting a menE gene-deleted prokaryotic host cell wherein said prokaryotic host cell has been transformed with a nucleic acid encoding said recombinant protein, (b) harvesting said recombinant protein; and (c) purifying said recombinant protein to a filtered bulk, wherein said filtered bulk does not contain detectable DHNA-recombinant protein adduct, as measured by an IEC assay at 310 nm, and wherein the recombinant protein yield is increased by about 20% or greater.
Claims
exact text as granted — not AI-modified1 . A method of producing a recombinant protein comprising (a) fermenting a prokaryotic host cell wherein said prokaryotic host cell has been transformed with a nucleic acid encoding said recombinant protein, and (b) harvesting said recombinant protein under conditions where dissolved oxygen (dO 2 ) levels are greater than 0%, and (c) purifying said recombinant protein to a filtered bulk for storage (FBS), wherein said filtered bulk does not contain detectable 1,4-dihydroxy-2-naphthoate (DHNA)-recombinant protein adduct, as measured by an ion exchange chromatography (IEC) assay at 310 nm.
2 . The method of claim 1 , wherein said analytical assay is by HPLC, RP HPLC, HIC HPLC, NMR, mass spectrometry, or UV spectroscopy.
3 . The method of claim 1 , wherein said dO 2 is maintained at levels greater than 0% continuously throughout the harvest operations of step (b).
4 . The method of claim 3 , wherein the harvest operations comprise a homogenization stage.
5 . The method of claim 4 , wherein said dO 2 is maintained at about 30% to about 75% prior to homogenization.
6 . The method of claim 4 , wherein said dO 2 is maintained at levels greater than 75% prior to homogenization.
7 . The method of claim 4 or 5 , wherein said dO 2 is maintained at about 50% after homogenization.
8 . The method of claim 4 , wherein said dO 2 is maintained at levels greater than 50% after homogenization.
9 . The method of claim 5 , wherein said dO 2 is maintained for a period of greater than or equal to 1.5 hours.
10 . (canceled)
11 . The method of claim 1 , wherein said dO 2 is maintained with overlay or sparged air, with increased back-pressure, or with agitation rate.
12 . The method of claim 11 , wherein the overlay air is from about 0.4 vvm to about 0.8 vvm.
13 . (canceled)
14 . The method of claim 11 , wherein the increased backpressure is between about 1.0 to 30 psi.
15 . The method of claim 14 , wherein the increase backpressure is targeted at 19 psi.
16 . The method of claim 11 , wherein the agitation rate is from about 6 Watts/L to about 8 Watts/L.
17 . (canceled)
18 . A method of producing a recombinant protein comprising (a) fermenting a menE gene-deleted prokaryotic host cell wherein said prokaryotic host cell has been transformed with a nucleic acid encoding said recombinant protein, (b) harvesting said recombinant protein; and (c) purifying said recombinant protein to a FBS, wherein said filtered bulk does not contain detectable 1,4-dihydroxy-2-naphthoate (DHNA)-recombinant protein adduct, as measured by an ion exchange chromatography (IEC) assay at 310 nm.
19 . (canceled)
20 . (canceled)
21 . The method of claim 1 , wherein said recombinant protein is a recombinant polypeptide or an isolated antibody.
22 . The method of claim 1 , wherein said prokaryotic host cell is Escherichia coli (E. coli), Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsiella, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, and Paracoccus.
23 . A method of generating a menE gene-deleted E. coli host cell comprising
transforming an E. coli cell with a PCR product comprising a resistance cassette for kanamycin flanked by FLP recognition target sites and a 50 base pair homology to chromosomal sequences adjacent to the menE gene and selecting for kanamycin resistance, and thereby generating a menE gene deleted E. coli cell.
24 . A prokaryotic host cell comprising a deletion in the menE gene and a nucleic acid encoding a recombinant protein.Join the waitlist — get patent alerts
Track US2023069966A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.